Alnylam Pharma (ALNY) – Hot Corp. News
-
Alnylam Pharma (ALNY) Announces Receipt of CRL from U.S. FDA for sNDA for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
-
Alnylam Pharma (ALNY) Reports Positive FDA AdCom Meeting on Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ALNY Stock Lookup